Telix Pharmaceuticals has officially opened a multi-million dollar radiopharmaceutical research, manufacturing and treat...
A CEPI-backed vaccine candidate developed by the University of Oxford’s Oxford Vaccine Group has become the first ...
US-based GEM Global Yield LLC SCS has executed a Share Purchase Agreement (SPA) with the existing shareholders of Taiwan...
Japanese pharma firm Takeda and the Indonesian Government (the Ministry of Health, the Ministry of Investment and D...
The Department of Health – Abu Dhabi (DoH), the regulator of the healthcare sector in the Emirate, alongside Astra...
India's Godavari Biorefineries has been granted a patent by the Japan Patent Office for its breakthrough invention, "5-H...
Bristol Myers Squibb (BMS), a global biopharmaceutical leader, recently celebrated its 60th anniversary in Singapore by ...
Lotus Pharmaceutical, a global pharmaceutical company headquartered in Taiwan, has announced that its wholly owned subsi...
Japan-based Tanabe Pharma has decided to transfer the domestic manufacturing and marketing approvals, manufacturing and ...
ADCs continue to represent a major growth area for drug developers, with the market projected to reach $69B by 20291. As...
University College London (UCL) and Japanese pharma firm Eisai have signed a new agreement to extend their long-standing...
Shilpa Medicare has announced that its wholly owned subsidiary, Shilpa Biologicals has entered into a co-development and...
China-based Sanyou Biopharmaceutical and Guangzhou Baiyunshan Xihe Health Pharmaceutical have jointly announced the offi...
The Faculty of Pharmacy, Mahidol University (MUPY), Thailand, has signed a Memorandum of Understanding (MoU) with We-Win...
Cadila Pharmaceuticals, one of India’s leading integrated pharmaceutical companies, and Wellesta Holdings, Singapo...
Arcera Life Sciences, a global life sciences company focused on advancing innovative and sustainable healthcare solution...
Eli Lilly Drugstore LLC (Lilly) and the Department of Health – Abu Dhabi (DoH), regulator of the healthcare sector...
Since the expansion, the Peenya facility has evolved into a key hub for Merck KGaA—what would you consider its mos...
The rapid growth of biologics and advanced therapies is placing new demands on supply chains, exposing infrastructure ga...
Zydus Lifesciences and Sunshine Healthcare have announced the setting up of a strategic joint venture (JV) company &ndas...
CStone Pharmaceuticals, a China-based biopharmaceutical company, has entered into an exclusive commercialisation agreeme...
Japan-based Nippon Shinyaku has entered into an option agreement with US-based Elixirgen Therapeutics, Inc. under which ...
Mubadala Bio has announced the signing of a licencing and supply agreement with Biosidus, a leading biotechnology compan...
CeleCor Therapeutics has completed submission of its New Drug Application to the U.S. FDA for zalunfiban, its investigat...
As biotech innovation accelerates, Asia emerges as an increasingly important hub, driv...
